cetacaine topical anesthetic

Generic: benzocaine, butamben, and tetracaine hydrochloride

Labeler: cetylite industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name cetacaine topical anesthetic
Generic Name benzocaine, butamben, and tetracaine hydrochloride
Labeler cetylite industries, inc.
Dosage Form GEL
Routes
TOPICAL
Active Ingredients

benzocaine .028 g/.2g, butamben .004 g/.2g, tetracaine hydrochloride .004 g/.2g

Manufacturer
Cetylite Industries, Inc.

Identifiers & Regulatory

Product NDC 10223-0217
Product ID 10223-0217_5e116134-85fa-4b04-9795-d55a361b07de
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 1960-01-01

Pharmacologic Class

Established (EPC)
standardized chemical allergen [epc]
Chemical Structure
allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 102230217
Hyphenated Format 10223-0217

Supplemental Identifiers

RxCUI
209970 308645
UNII
EFW857872Q 5NF5D4OPCI U3RSY48JW5
NUI
N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cetacaine topical anesthetic (source: ndc)
Generic Name benzocaine, butamben, and tetracaine hydrochloride (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • .028 g/.2g
  • .004 g/.2g
source: ndc
Packaging
  • 1 JAR in 1 BOX (10223-0217-3) / 32 g in 1 JAR
source: ndc

Packages (1)

10223-0217-3 1 JAR in 1 BOX (10223-0217-3) / 32 g in 1 JAR

Ingredients (3)

benzocaine (.028 g/.2g) butamben (.004 g/.2g) tetracaine hydrochloride (.004 g/.2g)

Linked Drug Pages (1)

Cetacaine Topical Anesthetic ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "5e116134-85fa-4b04-9795-d55a361b07de", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["EFW857872Q", "5NF5D4OPCI", "U3RSY48JW5"], "rxcui": ["209970", "308645"], "spl_set_id": ["9777acbb-8166-4734-9932-dc66b05bfcb5"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Cetylite Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 JAR in 1 BOX (10223-0217-3)  / 32 g in 1 JAR", "package_ndc": "10223-0217-3", "marketing_start_date": "19600101"}], "brand_name": "Cetacaine Topical Anesthetic", "product_id": "10223-0217_5e116134-85fa-4b04-9795-d55a361b07de", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Ester Local Anesthetic [EPC]", "Esters [CS]", "Increased Histamine Release [PE]", "Local Anesthesia [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "10223-0217", "generic_name": "Benzocaine, Butamben, and Tetracaine Hydrochloride", "labeler_name": "Cetylite Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cetacaine Topical Anesthetic", "active_ingredients": [{"name": "BENZOCAINE", "strength": ".028 g/.2g"}, {"name": "BUTAMBEN", "strength": ".004 g/.2g"}, {"name": "TETRACAINE HYDROCHLORIDE", "strength": ".004 g/.2g"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "19600101", "listing_expiration_date": "20261231"}